|
Primary brain tumor
Citations 61-70 of 161 total displayed.
|
Past content
(since Jan 2001):
|
- BRIEF COMMUNICATIONS
PCV chemotherapy for recurrent glioblastoma
- F. Schmidt, J. Fischer, U. Herrlinger, K. Dietz, J. Dichgans, and M. Weller
Neurology 2006; 66: 587-589.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Is protracted low-dose temozolomide feasible in glioma patients?
- A. Tosoni, G. Cavallo, M. Ermani, L. Scopece, E. Franceschi, C. Ghimenton, M. Gardiman, L. Pasetto, V. Blatt, and A. A. Brandes
Neurology 2006; 66: 427-429.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Surviving glioblastoma for more than 5 years: The patient's perspective
- J. P. Steinbach, H. -P. Blaicher, U. Herrlinger, W. Wick, T. Nägele, R. Meyermann, M. Tatagiba, M. Bamberg, J. Dichgans, H. -O. Karnath, and M. Weller
Neurology 2006; 66: 239-242.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Oligodendroglial tumor chemotherapy using "decreased-dose-intensity" PCV: A Singapore experience
- A. U. Ty, S. J. See, J. P. Rao, J.B.K. Khoo, and M. C. Wong
Neurology 2006; 66: 247-249.
[Abstract]
[Full text]
[PDF]
- NEUROIMAGES
An MRI view of a ruptured dermoid cyst
- Ulrike Ernemann, Johannes Rieger, Marcos Tatagiba, and Michael Weller
Neurology 2006; 66: 270.
[Full text]
[PDF]
- CLINICAL/SCIENTIFIC NOTES
Trends in acoustic neuroma and cellular phones: Is there a link?
- P. D. Nelson, M. B. Toledano, J. McConville, M. J. Quinn, N. Cooper, and P. Elliott
Neurology 2006; 66: 284-285.
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Matrilin-2 expression distinguishes clinically relevant subsets of pilocytic astrocytoma
- M. K. Sharma, M. A. Watson, M. Lyman, A. Perry, K. D. Aldape, F. Deák, and D. H. Gutmann
Neurology 2006; 66: 127-130.
[Abstract]
[Full text]
[PDF]
- CLINICAL/SCIENTIFIC NOTES
RAS pathway activation and an oncogenic RAS mutation in sporadic pilocytic astrocytoma
- Mukesh K. Sharma, Barbara A. Zehnbauer, Mark A. Watson, and David H. Gutmann
Neurology 2005; 65: 1335-1336.
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Primary central nervous system lymphomas (PCNSL): MRI response criteria revised
- W. Küker, T. Nägele, E. Thiel, M. Weller, and U. Herrlinger
Neurology 2005; 65: 1129-1131.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Primary CNS lymphoma complicating treatment of myasthenia gravis with mycophenolate mofetil
- Steven Vernino, Diva R. Salomao, Thomas M. Habermann, and Brian P. O’Neill
Neurology 2005; 65: 639-641.
[Abstract]
[Full text]
[PDF]
|
|
